Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

07/16/2014 | 08:45pm US/Eastern

By a News Reporter-Staff News Editor at Cancer Weekly -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with Merck KGaA's strategic approach in personalized medicine, the aim is to develop a patient stratifying diagnostic test that can be used in multiple cancer indications. Merck KGaA, which is actively investing in innovation in the CDx field through a number of partnerships, will leverage Ventana's global leadership position in cancer diagnostics and vast expertise in CDx to achieve new levels of diagnostic clarity for the investigated target. As part of the agreement, Ventana will develop and validate the CDx and ensure its readiness, availability, and adherence to FDA and other health authority standards for future clinical trials (see also Ventana Medical Systems, Inc.).

"Tailoring therapies based on a patient's specific genes, proteins or tissue environment is a key expansion area for oncology. We are very pleased to partner with Merck in Darmstadt, Germany to co-develop a CDx that will play a vital role in improving the quality of care for cancer patients," said Doug Ward, Vice President, Companion Diagnostics, Ventana Medical Systems, Inc. "Ventana is committed to continuing to provide the industry's gold standard in biomarker detection using our proprietary assays as the basis for novel companion diagnostic tests."

This pharma partnership is one of several currently underway where the Ventana Companion Diagnostics team is delivering patient stratifying diagnostic tests that help identify those patients who are most likely to benefit from specific treatments. In addition to the biopharmaceutical division of Merck KGaA, Ventana has announced partnerships with Bayer, Pfizer, Boehringer Ingelheim, Takeda's Millennium unit, Genmab, Incyte, MedImmune and more. Since 2002, the company has worked with more than 45 biopharmaceutical partners and is currently engaged in more than 180 collaborative projects to develop and commercialize companion diagnostics globally.

Companion diagnostics (CDx) are tests designed to confirm the presence of a specific biomarker to assist physicians in selecting effective therapies for their patients, based on the individual characteristics of each person. Incorporating a companion diagnostic strategy into a drug development program may expedite the drug approval process and help generate more effective treatments with improved safety profiles for patients.

Keywords for this news article include: Cancer, Genetics, Oncology, Ventana Medical Systems Inc.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

(c) 2014 NewsRx LLC

React to this article
Latest news
Date Title
12:12a LG ELECTRONICS : and Shaker Group unveil new AC lineup
12:12a FORD MOTOR : launches "Intelligent Speed Limiter"
12:01a FARM CREDIT BANK OF TEXAS : Carolina Farm Credit Holds 15th Annual Ag Leadership Institute
03/28 ADVANTECH : Integrated In-vehicle and Outdoor Video Surveillance Solutions Achieve High Efficiency, Lower TCO
03/28 HERBERT HAINER : 5 questions about the future of Adidas
03/28 VIACOM : Angelina Jolie Pitt, Liam Hemsworth, Emma Stone, Jennifer Lawrence, One Direction, Selena Gomez, SpongeBob SquarePants, Fifth Harmony, The Voice, Austin & Ally and More Win Top Honors at Nickelodeon's 28th Annual Kids' Choice Awards
03/28 CENTRAL PEOPLE GOVERNMENT OF PEOPLE RE : Australia to join AIIB
03/28 WAL MART STORES : Birge Leads Pros Into Final Day Of Walmart FLW Tour On Lewis Smith Lake Presented By Evinrude
03/28 BANK OF AMERICA : Downtown tower receives new name
03/28 A BROWN : Voter's guide
Latest news
Advertisement
Hot News 
JUDGES SCIENTIFIC : Profit Up But Like-For-Like Revenue Shrinks
MELROSE BANCORP : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
OHR PHARMACEUTICAL : Announces Final Topline Data From OHR-102 Phase II IMPACT Study in Wet-AMD
ANDREWS SYKES : Temporary arena in London requires replacement heating
RBC BEARINGS : Nasdaq stocks posting largest percentage increases
Most Read News
03/28 F SECURE : Hypponen Reviews the State of the Internet
03/28 KROGER : Legislators smacked with hard questions
03/28 SHAFTESBURY : Big trouble in little Chinatown as rent rises force restaurant owners out
03/28 GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
03/28 PAKISTAN AIRLINES : Government makes plans for Yemen evacuation
Most recommended articles
03/28DJPuerto Rico's Power Utility Gets Financing Offer -- Reuters
03/28DJBoko Haram Militants Kill 39, Disrupting Nigerian Presidential Voting -- 4th Update
03/28 Dufry to buy Italy's World Duty Free in 2.6 billion pound deal
03/28DJNigeria Extends Presidential Voting in Some Areas -- 3rd Update
03/28 Barrick Chairman Thornton gets nearly $13 million in 2014 compensation
Dynamic quotes  
ON
| OFF